Page last updated: 2024-09-05

phosphatidylcholines and Zygomycosis

phosphatidylcholines has been researched along with Zygomycosis in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	7 (87.50)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Perfect, JR	2
Alexander, D; Crompton, JA; Shihab, FS; Somerville, T	1
Chandrasekar, P	1
Forrest, GN; Mankes, K	1
Bandettini, R; Di Marco, E; Mantero, E; Tamisani, AM; Tuo, P	1
Edwards, JE; Fu, Y; Gebremariam, T; Husseiny, MI; Ibrahim, AS; Spellberg, B; Stevens, DA	1
Arndt, C; Chanock, SJ; Dinubile, MJ; Harris, RE; Hiemenz, J; Reboli, A; Seibel, NL; Walsh, TJ	1

Reviews

1 review(s) available for phosphatidylcholines and Zygomycosis

Article	Year
Use of newer antifungal therapies in clinical practice: what do the data tell us? Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis	2004

Article

Year

Use of newer antifungal therapies in clinical practice: what do the data tell us?

Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7

Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis

2004

Trials

1 trial(s) available for phosphatidylcholines and Zygomycosis

Article	Year
Amphotericin B lipid complex in pediatric patients with invasive fungal infections. The Pediatric infectious disease journal, 1999, Volume: 18, Issue:8 Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Creatinine; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Zygomycosis	1999

Article

Year

Amphotericin B lipid complex in pediatric patients with invasive fungal infections.

The Pediatric infectious disease journal, 1999, Volume: 18, Issue:8

Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Creatinine; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Zygomycosis

1999

Other Studies

6 other study(ies) available for phosphatidylcholines and Zygomycosis

Article	Year
Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient. Transplant infectious disease : an official journal of the Transplantation Society, 2004, Volume: 6, Issue:4 Topics: Amphotericin B; Antifungal Agents; Creatinine; Drug Combinations; Humans; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Zygomycosis	2004
Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, May-01, Volume: 40 Suppl 6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Female; Fusarium; Humans; Immunocompromised Host; Infant; Kidney; Male; Middle Aged; Mycoses; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Registries; Retrospective Studies; Treatment Outcome; Zygomycosis	2005
The experience is CLEAR. International journal of antimicrobial agents, 2006, Volume: 27 Suppl 1 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Cryptococcosis; Databases, Factual; Drug Combinations; Humans; In Vitro Techniques; Multicenter Studies as Topic; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prospective Studies; Treatment Outcome; Zygomycosis	2006
Outcomes of invasive zygomycosis infections in renal transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:2 Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Kidney Transplantation; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Risk Factors; Zygomycosis	2007
Severe cutaneous zygomycosis: evaluation of treatment with high doses of liposomal amphotericin B in a one-year old child. Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:3 Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Combinations; Humans; Immunocompromised Host; Infant; Phosphatidylcholines; Phosphatidylglycerols; Zygomycosis	2007
Comparison of lipid amphotericin B preparations in treating murine zygomycosis. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Amphotericin B; Animals; Antifungal Agents; Diabetic Ketoacidosis; Disease Models, Animal; Drug Combinations; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Rhizopus; Treatment Outcome; Zygomycosis	2008